Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC.
Mol Oncol. 2019 Dec;13(12):2604-2615. doi: 10.1002/1878-0261.12571. Epub 2019 Sep 22.
Mol Oncol. 2019.
PMID: 31505091
Free PMC article.
The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery.
Öjlert ÅK, Halvorsen AR, Nebdal D, Lund-Iversen M, Solberg S, Brustugun OT, Lingjaerde OC, Helland Å.
Öjlert ÅK, et al.
Mol Oncol. 2019 May;13(5):1166-1179. doi: 10.1002/1878-0261.12475. Epub 2019 Apr 10.
Mol Oncol. 2019.
PMID: 30854794
Free PMC article.
Clinical Trial.
Item in Clipboard
Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients.
Halvorsen AR, Haugen MH, Öjlert ÅK, Lund-Iversen M, Jørgensen L, Solberg S, Mælandsmo GM, Brustugun OT, Helland Å.
Halvorsen AR, et al. Among authors: ojlert ak.
Front Oncol. 2020 Nov 25;10:590755. doi: 10.3389/fonc.2020.590755. eCollection 2020.
Front Oncol. 2020.
PMID: 33324562
Free PMC article.
Item in Clipboard
Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer - predictors of response and impact of previous radiotherapy.
Öjlert ÅK, Nebdal D, Lund-Iversen M, Åstrøm Ellefsen R, Brustugun OT, Gran JM, Halvorsen AR, Helland Å.
Öjlert ÅK, et al.
Acta Oncol. 2021 Feb;60(2):149-156. doi: 10.1080/0284186X.2020.1854851. Epub 2020 Dec 24.
Acta Oncol. 2021.
PMID: 33356733
Item in Clipboard
Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor.
Öjlert ÅK, Nebdal D, Snapkov I, Olsen V, Kidman J, Greiff V, Chee J, Helland Å.
Öjlert ÅK, et al.
Mol Oncol. 2021 Nov;15(11):2958-2968. doi: 10.1002/1878-0261.13082. Epub 2021 Sep 1.
Mol Oncol. 2021.
PMID: 34402187
Free PMC article.
Item in Clipboard
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial.
Horndalsveen H, Alver TN, Dalsgaard AM, Rogg LV, Helbekkmo N, Grønberg BH, Halvorsen TO, Ramberg C, Haakensen VD, Öjlert ÅK, Bjaanaes MM, Helland Å.
Horndalsveen H, et al. Among authors: ojlert ak.
Mol Oncol. 2023 Mar;17(3):487-498. doi: 10.1002/1878-0261.13330. Epub 2022 Nov 22.
Mol Oncol. 2023.
PMID: 36330681
Free PMC article.
Clinical Trial.
Item in Clipboard
UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial.
Haakensen VD, Öjlert ÅK, Thunold S, Farooqi S, Nowak AK, Chin WL, Grundberg O, Szejniuk WM, Cedres S, Sørensen JB, Dalen TS, Lund-Iversen M, Bjaanæs M, Helland Å.
Haakensen VD, et al. Among authors: ojlert ak.
Eur J Cancer. 2024 May;202:113973. doi: 10.1016/j.ejca.2024.113973. Epub 2024 Mar 1.
Eur J Cancer. 2024.
PMID: 38447379
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite